The CJC-1295 + Ipamorelin Blend 10mg is a premium research-grade peptide formulation developed for laboratory investigations involving growth hormone signaling, neuroendocrine regulation, and IGF-1 pathway research. Manufactured to rigorous quality standards, each batch undergoes third-party analytical testing and includes Certificate of Analysis (COA) documentation for verified purity and consistency. Supplied as a lyophilized powder, this peptide blend is intended exclusively for scientific research conducted by qualified professionals.
For research use only. Not intended for human consumption or clinical use.
Premium Laboratory Quality
Batch-Specific Documentation
Identity & Purity Verified
Worldwide Delivery
$72.00
The CJC-1295 + Ipamorelin Blend 10mg combines two extensively studied synthetic peptides that target complementary mechanisms involved in growth hormone signaling. Within research settings, this combination is frequently selected to investigate the interaction between growth hormone-releasing hormone (GHRH) receptor activation and ghrelin receptor (GHS-R1a) stimulation under controlled laboratory conditions.
CJC-1295 is a modified GHRH analog designed to provide prolonged receptor engagement through albumin-binding technology, while Ipamorelin is recognized for its selective interaction with the ghrelin receptor, making it valuable for studying pulsatile growth hormone signaling. Together, these peptides allow researchers to examine coordinated endocrine responses, receptor pharmacology, and downstream signaling pathways associated with somatotropic regulation.
At Appex Peptide Lab, every batch is manufactured according to stringent quality standards and independently verified for purity and identity. Comprehensive quality documentation, secure packaging, and rapid shipping help research laboratories maintain confidence in every purchase.
Designed exclusively for scientific investigation, this peptide blend is widely used in universities, biotechnology companies, pharmaceutical research organizations, and life science laboratories throughout the United States, Canada, and Australia.
Researchers require dependable materials that support reproducibility and documented quality. The CJC-1295 + Ipamorelin Blend 10mg is selected by laboratories because it combines two well-characterized research peptides in a single formulation while maintaining high manufacturing and analytical standards.
Key advantages include:
This peptide blend is commonly investigated in laboratory studies involving:
Research examining interactions between GHRH receptors and growth hormone secretagogue receptors.
Studies evaluating endocrine communication pathways and hormonal signaling networks.
Experimental investigations into downstream signaling associated with growth hormone activity.
Evaluation of peptide-receptor affinity, selectivity, and signaling characteristics.
Research involving intracellular signaling cascades initiated by peptide receptor activation.
Laboratory assessments of peptide formulation, handling, storage, and stability.
| Specification | Details |
|---|---|
| Product Name | CJC-1295 + Ipamorelin Blend 10mg |
| Total Content | 10 mg |
| Peptide Components | CJC-1295 DAC + Ipamorelin |
| Purity | ≥98% (HPLC Verified) |
| Appearance | White to off-white lyophilized powder |
| Molecular Formula | Proprietary peptide blend |
| Molecular Weight | Component-specific |
| CAS Number | Component-specific |
| Solubility | Soluble following laboratory reconstitution procedures |
| Storage | Store at -20°C for long-term stability; refrigerate after reconstitution according to laboratory protocols |
| Sequence | CJC-1295 DAC and Ipamorelin peptide sequences verified by analytical testing |
CJC-1295 and Ipamorelin interact with distinct yet complementary receptor systems frequently investigated in endocrine research.
CJC-1295 functions as a synthetic analog of growth hormone-releasing hormone (GHRH), allowing researchers to study prolonged receptor engagement and downstream signaling. Ipamorelin selectively interacts with the growth hormone secretagogue receptor (GHS-R1a), making it valuable for examining pulsatile receptor activation and associated intracellular pathways.
Because these peptides engage different receptors involved in growth hormone regulation, researchers often investigate their combined effects on signaling dynamics, receptor cross-talk, and endocrine pathway modulation. These laboratory studies contribute to a broader understanding of peptide pharmacology and molecular signaling without implying clinical or therapeutic applications.
Every CJC-1295 + Ipamorelin Blend 10mg supplied by Appex Peptide Lab undergoes comprehensive quality control procedures designed to support scientific research.
Quality standards include:
Researchers worldwide trust Appex Peptide Lab for dependable research materials supported by transparent quality standards.
Premium peptides manufactured exclusively for scientific research.
Every production batch is verified through third-party analytical testing.
Reliable delivery throughout:
Each production lot is evaluated to support reproducible laboratory research.
Knowledgeable assistance is available for product documentation, ordering, and technical inquiries.
[sp_eap_template id=”7183″]
| Weight | .125 lbs |
|---|---|
| Dimensions | 9 × 7 × .5 in |
Premium Laboratory Quality
Batch-Specific Documentation
Identity & Purity Verified
Worldwide Delivery
$72.00
The CJC-1295 + Ipamorelin Blend 10mg combines two extensively studied synthetic peptides that target complementary mechanisms involved in growth hormone signaling. Within research settings, this combination is frequently selected to investigate the interaction between growth hormone-releasing hormone (GHRH) receptor activation and ghrelin receptor (GHS-R1a) stimulation under controlled laboratory conditions.
CJC-1295 is a modified GHRH analog designed to provide prolonged receptor engagement through albumin-binding technology, while Ipamorelin is recognized for its selective interaction with the ghrelin receptor, making it valuable for studying pulsatile growth hormone signaling. Together, these peptides allow researchers to examine coordinated endocrine responses, receptor pharmacology, and downstream signaling pathways associated with somatotropic regulation.
At Appex Peptide Lab, every batch is manufactured according to stringent quality standards and independently verified for purity and identity. Comprehensive quality documentation, secure packaging, and rapid shipping help research laboratories maintain confidence in every purchase.
Designed exclusively for scientific investigation, this peptide blend is widely used in universities, biotechnology companies, pharmaceutical research organizations, and life science laboratories throughout the United States, Canada, and Australia.
Researchers require dependable materials that support reproducibility and documented quality. The CJC-1295 + Ipamorelin Blend 10mg is selected by laboratories because it combines two well-characterized research peptides in a single formulation while maintaining high manufacturing and analytical standards.
Key advantages include:
This peptide blend is commonly investigated in laboratory studies involving:
Research examining interactions between GHRH receptors and growth hormone secretagogue receptors.
Studies evaluating endocrine communication pathways and hormonal signaling networks.
Experimental investigations into downstream signaling associated with growth hormone activity.
Evaluation of peptide-receptor affinity, selectivity, and signaling characteristics.
Research involving intracellular signaling cascades initiated by peptide receptor activation.
Laboratory assessments of peptide formulation, handling, storage, and stability.
| Specification | Details |
|---|---|
| Product Name | CJC-1295 + Ipamorelin Blend 10mg |
| Total Content | 10 mg |
| Peptide Components | CJC-1295 DAC + Ipamorelin |
| Purity | ≥98% (HPLC Verified) |
| Appearance | White to off-white lyophilized powder |
| Molecular Formula | Proprietary peptide blend |
| Molecular Weight | Component-specific |
| CAS Number | Component-specific |
| Solubility | Soluble following laboratory reconstitution procedures |
| Storage | Store at -20°C for long-term stability; refrigerate after reconstitution according to laboratory protocols |
| Sequence | CJC-1295 DAC and Ipamorelin peptide sequences verified by analytical testing |
CJC-1295 and Ipamorelin interact with distinct yet complementary receptor systems frequently investigated in endocrine research.
CJC-1295 functions as a synthetic analog of growth hormone-releasing hormone (GHRH), allowing researchers to study prolonged receptor engagement and downstream signaling. Ipamorelin selectively interacts with the growth hormone secretagogue receptor (GHS-R1a), making it valuable for examining pulsatile receptor activation and associated intracellular pathways.
Because these peptides engage different receptors involved in growth hormone regulation, researchers often investigate their combined effects on signaling dynamics, receptor cross-talk, and endocrine pathway modulation. These laboratory studies contribute to a broader understanding of peptide pharmacology and molecular signaling without implying clinical or therapeutic applications.
Every CJC-1295 + Ipamorelin Blend 10mg supplied by Appex Peptide Lab undergoes comprehensive quality control procedures designed to support scientific research.
Quality standards include:
Researchers worldwide trust Appex Peptide Lab for dependable research materials supported by transparent quality standards.
Premium peptides manufactured exclusively for scientific research.
Every production batch is verified through third-party analytical testing.
Reliable delivery throughout:
Each production lot is evaluated to support reproducible laboratory research.
Knowledgeable assistance is available for product documentation, ordering, and technical inquiries.
[sp_eap_template id=”7183″]
| Weight | .125 lbs |
|---|---|
| Dimensions | 9 × 7 × .5 in |
